Igawa S - Search Results

1

Rationale and protocol design of a phase II study of first-line osimertinib treatment for patients with poor performance status and EGFR mutation-positive non-small cell lung cancer (OPEN/TORG2040).

Fukui T, Sasaki J, Igawa S, Kada A, Saito TI, Kogure Y, Okamoto H, Naoki K. Fukui T, et al. Among authors: igawa s. BMC Cancer. 2022 Dec 15;22(1):1314. doi: 10.1186/s12885-022-10409-6. BMC Cancer. 2022. PMID: 36522630 Free PMC article.

2

Efficacy of amrubicin for non-small cell lung cancer after failure of two or more prior chemotherapy regimens.

Igawa S, Takahashi T, Nakamura Y, Tsuya A, Ono A, Shukuya T, Murakami H, Endo M, Yamamoto N. Igawa S, et al. Anticancer Res. 2008 Nov-Dec;28(6B):3855-8. Anticancer Res. 2008. PMID: 19192640 Free article.

3

Successful rechallenge with erlotinib in a patient with EGFR-mutant lung adenocarcinoma who developed gefitinib-related interstitial lung disease.

Fukui T, Otani S, Hataishi R, Jiang SX, Nishii Y, Igawa S, Mitsufuji H, Kubota M, Katagiri M, Masuda N. Fukui T, et al. Among authors: igawa s. Cancer Chemother Pharmacol. 2010 Mar;65(4):803-6. doi: 10.1007/s00280-009-1212-5. Epub 2009 Dec 25. Cancer Chemother Pharmacol. 2010. PMID: 20035424

4

Amrubicin for treating elderly and poor-risk patients with small-cell lung cancer.

Igawa S, Ryuge S, Fukui T, Otani S, Kimura Y, Katono K, Takakura A, Kubota M, Mitsufuji H, Katagiri M, Yanase N, Masuda N. Igawa S, et al. Int J Clin Oncol. 2010 Oct;15(5):447-52. doi: 10.1007/s10147-010-0085-2. Epub 2010 May 13. Int J Clin Oncol. 2010. PMID: 20464623

5

Phase II study of S-1 monotherapy in patients with previously treated, advanced non-small-cell lung cancer.

Wada M, Yamamoto M, Ryuge S, Nagashima Y, Hayashi N, Maki S, Otani S, Katono K, Takakura A, Yanaihara T, Igawa S, Yokoba M, Mitsufuji H, Kubota M, Katagiri M, Masuda N. Wada M, et al. Among authors: igawa s. Cancer Chemother Pharmacol. 2012 Apr;69(4):1005-11. doi: 10.1007/s00280-011-1795-5. Epub 2011 Dec 8. Cancer Chemother Pharmacol. 2012. PMID: 22160350 Clinical Trial.

6

[Pemetrexed as second-line treatment and beyond for elderly patients with advanced non-small-cell lung cancer].

Otani S, Igawa S, Maki S, Nagashima Y, Hayashi N, Kimura M, Ishihara M, Kasajima S, Hiyoshi Y, Katono K, Takakura A, Mitsufuji H, Katagiri M, Kubota M, Masuda N. Otani S, et al. Among authors: igawa s. Gan To Kagaku Ryoho. 2012 Jan;39(1):59-62. Gan To Kagaku Ryoho. 2012. PMID: 22241352 Japanese.

7

Impacts of treatment lines and initiation timing of erlotinib for advanced non-small cell lung cancer.

Aoki T, Igawa S, Furuya N, Katagiri M, Hisata J, Tajiri S, Hayama N, Mineshita M, Urano T, Miyazawa T, Masuda N, Abe T. Aoki T, et al. Among authors: igawa s. Anticancer Res. 2012 Feb;32(2):601-8. Anticancer Res. 2012. PMID: 22287751

8

Phase I trial of irinotecan and amrubicin with granulocyte colony-stimulating factor support in extensive-stage small-cell lung cancer.

Asakuma M, Yamamoto M, Wada M, Ryuge S, Katono K, Yokoba M, Fukui T, Takakura A, Otani S, Maki S, Igawa S, Yanaihara T, Mitsufuji H, Kubota M, Katagiri M, Sasaki J, Masuda N. Asakuma M, et al. Among authors: igawa s. Cancer Chemother Pharmacol. 2012 Jun;69(6):1529-36. doi: 10.1007/s00280-012-1858-2. Epub 2012 Mar 14. Cancer Chemother Pharmacol. 2012. PMID: 22415148 Clinical Trial.

9

Rapid deconjugation of SN-38 glucuronide and adsorption of released free SN-38 by intestinal microorganisms in rat.

Takakura A, Kurita A, Asahara T, Yokoba M, Yamamoto M, Ryuge S, Igawa S, Yasuzawa Y, Sasaki J, Kobayashi H, Masuda N. Takakura A, et al. Among authors: igawa s. Oncol Lett. 2012 Mar;3(3):520-524. doi: 10.3892/ol.2011.519. Epub 2011 Dec 9. Oncol Lett. 2012. PMID: 22740943 Free PMC article.

10

Pemetrexed for previously treated patients with non-small cell lung cancer and differences in efficacy according to thymidylate synthase expression.

Igawa S, Ryuge S, Wada M, Otani S, Maki S, Takakura A, Katono K, Sasaki J, Sato Y, Masuda N. Igawa S, et al. Chemotherapy. 2012;58(4):313-20. doi: 10.1159/000343048. Epub 2012 Nov 7. Chemotherapy. 2012. PMID: 23147191

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

196 results

Search Page